Verified email-pattern data for Medpacto is currently limited. You can still use the company insights and contact sections below.
MedPacto is a genome-based drug discovery and clinical-stage biotechnology company that is pursuing the development of first-in-class therapies to bring new hope to patients suffering from the most challenging diseases such as cancer. The leading drug candidate is Vactosertib, an orally bioavailable small-molecule inhibitor of the TGF-β type I receptor (TβRI) currently in phaseⅡ clinical trials with global pharmaceutical companies such as Merck and AstraZeneca.
Vactosertib inhibits transforming growth factor-beta (TGF-β) pathway signaling, which is known to promote the metastasis and proliferation of cancer cells by modulating the tumor microenvironment. Vactosertib plays a synergistic role in improving the response to various therapies by inhibiting immune-suppressive TGF-β activity and suppressing the resistance mechanism of cancer stem cells.
MedPacto is currently conducting combination trials with Vactosertib targeting several cancer indications including colorectal cancer, pancreatic cancer, sarcomas, NSCLC, bladder cancer, and gastric cancer.
Additionally, MedPacto is currently developing MP005A, a new antibody therapeutics targeting BAG2 protein which promotes tumor formation and lung metastasis by binding the enzymes that regulate the tumor microenvironment in cancer development, and MP005D, a diagnostic kit that can detect BAG2 genes.
Company Details
- Employees
- 21
- Founded
- -
- Address
- 92, Myeongdal-Ro, Seocho-Gu,korea, Republic Of
- Industry
- Biotechnology Research
- Website
- http://www.medpacto.com/
- HQ
- Seoul
Medpacto Questions
MedPacto's website is http://www.medpacto.com/
MedPacto's LinkedIn profile is https://kr.linkedin.com/company/medpacto
MedPacto has
21 employees.
View email and phone details for 21
employees at MedPacto.
MedPacto's industry is
Biotechnology Research
MedPacto's top competitors are
Memorial Sloan Kettering Cancer Center,
Etihad,
Evotec,
Galderma,
Aglaeapharma Inc,
Fortrea,
Teijin Limited,
Ucb,
Chime Biologics,
Hilleman Laboratories.
MedPacto's categories are Biotechnology Research
MedPacto's founding year is 2013
Explore related pages
Related company profiles:
Top MedPacto Employees
-
김연지(Yeonji Kim)
제약바이오분야 연구소 운영, 안전관리, 정부과제
Gangseo District, Seoul, South Korea, Korea, Republic Of -
Hyejin Kim
Medpacto - Principal Researcher
Seoul, South Korea, Korea, Republic Of -
Chanmoo Lee
Biopharmaceutical Cmc Specialist
Gyeonggi, South Korea, Korea, Republic Of -
EUNAH CHO
Pharmacist, Korean Lawyer, Mater'S Degree In Clinical Pharmacy
Seocho District, Seoul, South Korea, Korea, Republic Of
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.